Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- INCR.TA
- Price
- 484.20
- Stock movement up
- +14.20 (3.02%)
- Company name
- Intercure
- Exchange
- (TA ,
- Currency
- ILA )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 22.16B
- Ent value
- -
- Price/Sales
- 70.52
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 1623.65
- Forward P/E
- -
- PEG
- -
- EPS growth
- 14.53%
- 1 year return
- -50.49%
- 3 year return
- -40.07%
- 5 year return
- -40.46%
- 10 year return
- -24.22%
Last updated: 2025-04-15
DIVIDENDS
INCR.TA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 1623.65 |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 70.52 |
| Price to Book | - |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 45.77M |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 314.22M |
| Gross profit (TTM) | 92.83M |
| Operating income (TTM) | 13.13M |
| Net income (TTM) | 13.65M |
| EPS (TTM) | - |
| EPS (1y forward) | -0.04 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 29.54% |
| Operating margin (TTM) | 4.18% |
| Profit margin (TTM) | 4.34% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 102.65M |
| Net receivables | 134.37M |
| Total current assets | 394.50M |
| Goodwill | 284.18M |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 841.85M |
| Accounts payable | 104.61M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 207.75M |
| Total liabilities | 314.19M |
| Shareholder's equity | 527.65M |
| Net tangible assets | 224.58M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -105.08M |
| Capital expenditures (TTM) | 1.38M |
| Free cash flow (TTM) | -14.75M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 474.60 |
| Daily high | 496.70 |
| Daily low | 474.60 |
| Daily Volume | 28K |
| All-time high | 88985199991.10 |
| 1y analyst estimate | 26.64 |
| Beta | 0.03 |
| EPS (TTM) | - |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| INCR.TA | S&P500 | |
| Current price drop from All-time high | -100.00% | -12.04% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 14 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -77.92% | -11.07% |
| Avg time to new high | 5 days | 12 days |
| Max time to new high | 4342 days | 1805 days |
COMPANY DETAILS
Marketcap
22.16B
Marketcap category
Large-cap
Description
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
Employees
270
Website
Investor relations
-
SEC filings
CEO
Country
Israel
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), announces today that Mr. Ehud Barak will step down as Chairman of the board of directors of the Company (the "B...
February 12, 2025
InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), is pleased to announce that further to the Company's prior reports regarding the war-related damages and the re...
December 20, 2024
Key Takeaways; Cannabis Sector SNDL acquired Indiva in efforts to strengthen position in cannabis edibles market. Ascend Wellness overhauled leadership amid financial struggles. Avicanna reduced debt ...
September 1, 2024
Revenues during the first half of 2024 reached NIS 126 million, alongside an Adjusted EBITDA1of NIS 21 million (Approximately 17% of revenues).Both quarters (Q1 and Q2 of 2024) ended with positive EBI...
August 29, 2024
NEW YORK & HERZLIYA, Israel, August 28, 2024--InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading vertically integrated medical cannabis company outsid...
August 28, 2024
NEW YORK & HERZLIYA, Israel, May 22, 2024--InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc), the leading medical cannabis company outside of North America, today announced that it will partici...
May 22, 2024
InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million
NEW YORK & HERZLIYA, Israel, May 01, 2024--InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) ("InterCure" or the "Company") today announced results for the full year ending December 31, 2023. All amounts are...
May 1, 2024